Signal Advisors Wealth’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.77M Buy
22,938
+11,190
+95% +$2.41M 0.29% 68
2026
Q1
$2.55M Buy
11,748
+5,918
+102% +$1.31M 0.18% 109
2025
Q4
$1.33M Buy
5,830
+2,824
+94% +$643K 0.11% 162
2025
Q3
$696K Sell
3,006
-1,789
-37% -$364K 0.06% 218
2025
Q2
$890K Buy
4,795
+3,062
+177% +$569K 0.07% 223
2025
Q1
$363K Buy
1,733
+91
+6% +$17.7K 0.04% 334
2024
Q4
$292K Buy
1,642
+232
+16% +$42.7K 0.03% 367
2024
Q3
$278K Buy
+1,410
New +$263K 0.04% 358
2024
Q2
Sell
-1,825
Closed -$332K 76
2024
Q1
$332K Buy
+1,825
New +$315K 0.08% 218

Other funds holding ABBV

Signal Advisors Wealth's ABBV Position: Q2 2026 in Review

Signal Advisors Wealth increased its AbbVie (ABBV) stake by 95% in Q2 2026, buying an estimated $2.41M and bringing the position to 22,938 shares worth $5.77M. The position accounts for 0.29% of the portfolio, ranked #68.

Signal Advisors Wealth first reported a position in ABBV in Q1 2024 and has held it in 9 quarters since. 4,222 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Signal Advisors Wealth held 22,938 shares of AbbVie worth $5.77M as of Q2 2026.
  • Signal Advisors Wealth bought 11,190 AbbVie shares in Q2 2026, an estimated $2.41M.
  • AbbVie made up 0.29% of Signal Advisors Wealth's portfolio in Q2 2026, its #68 holding.
  • Signal Advisors Wealth first reported a position in AbbVie in Q1 2024 and has held it in 9 quarters since.
  • 4,222 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Signal Advisors Wealth's 13F filing for Q2 2026, filed 4 Aug 2026.